Almotan 6.25mg Tablet
- Manufacturer : MSN Laboratories
- Composition : Almotriptan 6.25mg
- Generally Prescribed For : Acute Migraine
- Estimated Price : ₹176.00 For 4 Tablets Strip
BUY FROM THESE SELLERS
Uses of Almotan 6.25mg TabletAlmotan 6.25mg Tablet is used for the treatment or prevention of the following disease(s):
Side effects of Almotan 6.25mg TabletThe most common side effects of Almotan 6.25mg Tablet are - Headache, Dizziness, Numbness, Nausea, Vomiting, Dry Mouth
These side effects can usually occur in patients. However, these are only indicative and not all patients will experience them.
Precautions while using Almotan 6.25mg TabletDo not use Almotan 6.25mg Tablet if you are allergic to - Almotriptan
If you have heart disease, liver or kidney disease, drug or alcohol addiction, consult your doctor before using Almotan 6.25mg Tablet.
If you are allergic to any medicine or food, consult your doctor before using this medicine.
Use this medicine under the supervision of your doctor.
To avoid an adverse reaction, consult your doctor if you are already taking other medicines.
How Almotan 6.25mg Tablet worksAlmotan 6.25mg Tablet contains - Almotriptan
Almotriptan may act as an agonist at serotonin receptors on extracerebral intracranial blood vessels, which constricts the affected vessels, inhibits neuropeptide release, and reduces pain transmission in the trigeminal pathways.
Dosage of Almotan 6.25mg TabletThe dosage of Almotan 6.25mg Tablet depends on many factors such as the patient age, health, medical condition or history of the patient and many other conditions.
Please use this medicine as prescribed by your doctor.
Overdose of Almotan 6.25mg TabletIf you forget to take a dose of Almotan 6.25mg Tablet, do not take two doses at the same time, there is a risk of overdose.
If you notice any unusual reaction in your body after taking this medicine, contact your doctor immediately or call your local medical emergency number.
Precautions & Warnings
InteractionDrug :- Antiemetics (5-HT antagonists), antipsychotics, metazolone, methylene blue, 3 metoclopramide, opioid analgesics, tramadol: May increase serotonergic effects and serotonin syndrome. Monitor therapy.
CYP3A4 inhibitors (such as ketoconazole): May increase almotriptan level. Monitor patient forpotential adverse reaction.
May need to reduce dosage. Avoid concomitant use in patients with renal or hepatic impairment.
Ergot-containing drugs, serotonin 5-HT agonists: May cause additive effects.
Avoid using 1B/1D within 24 hours of almotriptan.
MAO inhibitors, verapamil: May increase almotriptan level. No dose adjustment is necessary.
SSNRIs, SSRIs: May cause additive serotonin effects, resulting in weakness, hyperreflexia, or incoordination. Monitor patient closely if given together.